Cosmetic and Reconstructive Surgery
J15 · Effective May 28, 2023
5 active Medicare policies list Z80.3, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective May 28, 2023
J5 · Effective Nov 14, 2021
J8 · Effective Nov 14, 2021
J5 · Effective Jun 25, 2026
National · Effective Nov 27, 2025
6 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of Z80.3 |
|---|---|---|
| Breast Ductal Lavage and Fiberoptic Ductoscopy | Jul 12, 2023 | Covered |
| Genetic Testing | Feb 27, 2024 | Covered |
| Skin and Soft Tissue Substitutes | Feb 9, 2024 | Covered |
| Policy | Effective | Status of Z80.3 |
|---|---|---|
| Cancer Antigen 125 Testing | Oct 1, 2026 | Covered |
| Reduction Mammaplasty | Jul 1, 2026 |
| Covered |
| Policy | Effective | Status of Z80.3 |
|---|---|---|
| Concert Genetic Testing: Toxicology and Pharmacogenetics Version B | Not recorded | Referenced |